{"id":"W4317862685","doi":"10.1200/jco.2023.41.4_suppl.lba294","title":"INTEGRATE IIa: A randomised, double-blind, phase III study of regorafenib versus placebo in refractory advanced gastro-oesophageal cancer (AGOC)—A study led by the Australasian Gastro-intestinal Trials Group (AGITG).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; McGill University Health Centre","funders":"","keywords":"Medicine; Regorafenib; Internal medicine; Hazard ratio; Placebo; Population; Progression-free survival; Clinical endpoint; Cancer; Oncology; Clinical trial; Gastroenterology; Confidence interval; Colorectal cancer; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01926995,0.0004307861,0.004633007,0.0005925615,0.00009531236,0.00003132966,0.0006191233,0.0002495761,0.000325162],"category_scores_gemma":[0.00621574,0.0002622549,0.0008789438,0.001009195,0.00028319,0.0002465447,0.0001782713,0.002361355,0.000009385236],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004500675,"about_ca_system_score_gemma":0.001073134,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004657316,"about_ca_topic_score_gemma":0.002220536,"domain_scores_codex":[0.9886009,0.002617755,0.006577815,0.0005209218,0.001041833,0.0006407666],"domain_scores_gemma":[0.9851058,0.008312783,0.005199604,0.0004913934,0.0004646838,0.0004257211],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8146711,0.01198792,0.114895,0.00003594956,0.001785955,0.001810163,0.0009600841,0.0002504418,0.0001890346,0.000006472854,0.006449546,0.04695828],"study_design_scores_gemma":[0.8444107,0.06987944,0.05709449,0.0001424644,0.002249501,0.00003901002,0.02209931,0.0001155725,0.00002141812,0.000008064177,0.003782725,0.0001572984],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884074,0.0002099673,0.00007325539,0.003090345,0.003193639,0.004603892,0.0000106959,0.00003381728,0.0003769544],"genre_scores_gemma":[0.9961662,0.0003372167,0.0002014314,0.0001780686,0.001203503,0.0002005087,0.00001193691,0.0000411773,0.001660014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05789151,"threshold_uncertainty_score":0.999983,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2226914900011004,"score_gpt":0.5219122760889366,"score_spread":0.2992207860878362,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}